Trial Information

Summary: Are you no longer turned on when the lights turn off?

The purpose of the study is to determine the safety and effectiveness of LibiGel®, an investigational medication for Hypoactive Sexual Desire Disorder (HSDD). Physicians in your area are currently conducting the study.

Each woman will be evaluated to determine her eligibility. If you qualify, you’ll receive study medication, study-realted medical exams and lab tests at no charge. Financial compensation fro time and travel may also be available.

Patient Inclusion Criteria: If you’re a woman at least 30 years of age experiencing a decrease in sexual desire, you are invited to see if you may qualify for a medical research study. To qualify you must have gone through menopause or had your ovaries removed.

If you would like to learn more about participating in this study, please send an e-mail message using the form below.